Evidence map›Paper›PMID 40961111›Full record

ArticlePloS one2025

Predicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models.

Julian Müller-Kühnle, Moritz Schanz, Severin Schricker, Christian Benignus, Julia Todoroff, Jörg Latus, Wolfram Zoller, Dominik Marschner

Abstract readComparative Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julian Müller-KühnleDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.ORCID https://orcid.org/0009-0005-8849-5101
Moritz SchanzDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.
Severin SchrickerDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.
Christian BenignusParacelsus Medical University, Salzburg, Austria.
Julia TodoroffDepartment of Hematology, Oncology, Stem Cell Transplantation, and Palliative Medicine, Klinikum Stuttgart, Stuttgart, Germany.
Jörg LatusDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.
Wolfram ZollerDepartment of General Internal Medicine, Gastroenterology, Gastrointestinal Oncology, Hepatology, Infectious Diseases, and Pulmonology, Klinikum Stuttgart, Stuttgart, Germany.
Dominik MarschnerDepartment of Hematology, Oncology, Stem Cell Transplantation, and Palliative Medicine, Klinikum Stuttgart, Stuttgart, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal dysfunction is a frequent and clinically relevant complication of cirrhosis, yet chronic kidney disease (CKD) often remains underrecognized, particularly in non-acute settings. Early identification of at-risk patients is essential to guide timely interventions. Although MELD, Child-Pugh Score (CPS), APRI, and FIB-4 are widely used to assess hepatic disease severity, their predictive value for advanced renal dysfunction is uncertain.

methodsIn this retrospective cohort study (2014-2021, Klinikum Stuttgart), we evaluated the ability of MELD, CPS, APRI, and FIB-4 to predict severe renal dysfunction (chronic kidney disease [CKD] stage ≥ 3, according to Kidney Disease: Improving Global Outcomes [KDIGO] classification) in patients with alcoholic cirrhosis. Logistic and linear regression analyses were performed. In addition, machine learning (ML) models were trained to identify non-renal predictors of CKD stage ≥ 3.

resultsAmong 131 patients (mean age 62.8 ± 11.3 years; 71% male), 33% met criteria for KDIGO stage ≥ 3. MELD was significantly associated with advanced CKD (OR = 1.379, p < 0.001), with prevalence increasing from 17% (MELD ≤ 9) to 80% (MELD ≥ 20). CPS showed an inverse association (p = 0.002), while APRI and FIB-4 were not predictive. The optimized Random Forest model, refined through ROSE oversampling and feature selection, achieved an AUC of 0.757, with 76% accuracy, 82% sensitivity (KDIGO < 3), and 63% specificity (KDIGO ≥ 3).

conclusionMELD was the most reliable conventional score for identifying advanced renal dysfunction in alcoholic cirrhosis. ML-based models incorporating routinely available clinical parameters further improved predictive performance and may support risk stratification in this high-risk population.

Indexed as

Liver Cirrhosis, AlcoholicMachine LearningRenal Insufficiency, ChronicAgedFemaleHumansLiver Function TestsMaleMiddle AgedRetrospective StudiesSeverity of Illness Index

Identifiers

PMID40961111
PMCPMC12443302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.